HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 82149920122

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82149920122 and manufactured by CERTEST BIOTEC, S.L.. The registration is held by GENESTAR INOVAÇÕES E EQUIPAMENTOS MÉDICOS LTDA with validity until Jun 16, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
82149920122
2 Related Devices
Registration Details
ANVISA Registration Number: 82149920122
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

VIASURE CMV q Real Time PCR Detection Kit (tubes)
Risk Class IV

Registration Details

82149920122

25351027403202511

35489323000175

Company Information

Spain
PT: ESPANHA

Dates and Status

Jun 16, 2025

16/06/2035

09/18/2025 19:00:01

VIASURE CMV q Real Time PCR Detection Kit (tubes)
Risk Class IV

Registration Details

82149920122

25351027403202511

35489323000175

Company Information

Dates and Status

Jun 16, 2025

16/06/2035

09/18/2025 19:00:01